MORGAN STANLEY - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 44 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$175
-30.0%
2190.0%0.00%
Q2 2023$250
-99.9%
219
-99.8%
0.00%
Q1 2023$192,967
+51912.7%
128,644
+51564.3%
0.00%
Q4 2022$371
-98.2%
249
-98.2%
0.00%
Q3 2022$21,000
-64.4%
13,569
-48.2%
0.00%
Q2 2022$59,000
+136.0%
26,175
+136.1%
0.00%
Q1 2022$25,000
-88.3%
11,086
-69.9%
0.00%
Q4 2021$214,000
+511.4%
36,846
+1011.5%
0.00%
Q3 2021$35,000
-96.7%
3,315
-96.9%
0.00%
Q2 2021$1,051,000
+994.8%
107,726
+1538.4%
0.00%
Q1 2021$96,0006,5750.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders